research on glp 1 drugs Poll: in 8 Adults Say They Are Currently Taking a GLP-1 Drug for Weight Loss, Diabetes or Another Condition, Even as Half Say the Are Difficult to Afford The Power of Discovery: GLP-1
Description
60 capsules per bottle (30-day supply)

The most common designs are observational studies

At the same time, ultra-long-acting injectables are emerging as another theme of innovation

Encourages Lasting Weight Balance Built to promote steady, consistent progress rather than temporary fixes

Results The first cohort included 36082 GLP-1 receptor agonist users (median follow-up 1.3 years) and 234028 DPP-4 inhibitor users (median follow-up 1.7 years)
